Basal cell carcinoma (BCC) is the most common cancer in humans and the most common cancer of the skin. Two million Americans are diagnosed with BCC every year. It is a neoplasm of basal keratinocytes that is found more frequently in men than women. Rates of BCC have been increasing over the last several decades, particularly in young women. BCCs can be seen at almost any age. Nonetheless, the malignancy has greater incidence in older individuals, with a median age at diagnosis of 68 years.
There are many subtypes of BCC, including nodular, superficial, infundibulocystic, fibroepithelial, morpheaform (sclerosing, desmoplastic), infiltrative, micronodular, and basosquamous. Nodular BCC is the most common subtype overall and accounts for half of all lesions. In Black and Hispanic patients, BCCs are more often pigmented.
Nodular BCC is typically seen on the face, most commonly on the cheeks, nose, melolabial fold, forehead, and eyelids. Although BCCs typically arise in hair-bearing areas, they can rarely be seen in hairless genital mucosa for an unknown reason.
The greatest risk factor contributing to the development of BCCs is sun exposure, and people with light skin phototypes are at higher risk. Intermittent sun exposure is more associated with the development of BCCs than cumulative ultraviolet (UV) exposure. Other risk factors for BCCs include environmental exposure (ie, ionizing radiation, indoor tanning, chemicals such as arsenic, psoralen plus UVA, and coal tar), phenotype (freckling, red hair, light skin that always burns and never tans), immunosuppression such as organ transplantation (which results in a 5-10 times higher risk of BCCs than the general population), and various genetic syndromes including xeroderma pigmentosum, oculocutaneous albinism, Muir-Torre syndrome, basal cell nevus syndrome (Gorlin syndrome), Rombo syndrome, and Bazex-Dupré-Christol syndrome. The gene most frequently altered in BCCs is the PTCH1 gene, followed by the TP53 gene.
Although BCCs are almost never fatal, local tissue destruction and disfiguration occur. The metastasis rate of BCCs is approximately 1 in 35 000. Metastasis is rare and typically occurs through perineural spread, lymph node metastasis, and then lung / bone metastasis.
Nodular basal cell carcinoma - Hair and Scalp
See also in: Overview,External and Internal Eye,AnogenitalAlerts and Notices
Important News & Links
Synopsis
Codes
ICD10CM:
C44.91 – Basal cell carcinoma of skin, unspecified
SNOMEDCT:
403911008 – Nodulo-ulcerative basal cell carcinoma
C44.91 – Basal cell carcinoma of skin, unspecified
SNOMEDCT:
403911008 – Nodulo-ulcerative basal cell carcinoma
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
To perform a comparison, select diagnoses from the classic differential
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Subscription Required
References
Subscription Required
Last Reviewed:11/07/2021
Last Updated:01/29/2023
Last Updated:01/29/2023
Patient Information for Nodular basal cell carcinoma - Hair and Scalp
Premium Feature
VisualDx Patient Handouts
Available in the Elite package
- Improve treatment compliance
- Reduce after-hours questions
- Increase patient engagement and satisfaction
- Written in clear, easy-to-understand language. No confusing jargon.
- Available in English and Spanish
- Print out or email directly to your patient
Upgrade Today
Nodular basal cell carcinoma - Hair and Scalp
See also in: Overview,External and Internal Eye,Anogenital